Literature DB >> 8982401

Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis).

Y Teraki1, K Imanishi, T Shiohara.   

Abstract

Recent studies have suggested that cytokines play a critical role in the pathophysiology of alopecia areata; however, no information is available regarding the difference in cytokine profiles in these patients. Serum levels of cytokines, including interferon gamma (IFN-gamma), tumor necrosis factor alpha, interleukin 1 alpha (IL-1 alpha), IL-2, IL-4, and IL-6, were measured using radioimmunoassay or enzyme-linked immunosorbent assay techniques in patients with the localized form and the extensive form (alopecia universalis). The serum levels of IL-1 alpha and IL-4 were significantly elevated in patients with the localized form. In contrast, the serum levels of IFN-gamma and IL-2 were significantly elevated in patients with the extensive form. These results indicate that immune responses in the localized form and the extensive form of alopecia areata are regulated by Th2 cytokines and Th1 cytokines, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8982401     DOI: 10.2340/0001555576421423

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  23 in total

1.  Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.

Authors:  Doreen Nazeih Assaad Younan; Naglaa Agamia; Adel Elshafei; Nancy Ebeid
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

2.  Serum cytokine levels and anxiety and depression rates in patients with alopecia areata.

Authors:  Arzu Ataseven; Yunus Saral; Ahmet Godekmerdan
Journal:  Eurasian J Med       Date:  2011-08

3.  Alternaria scalp infection in a patient with alopecia areata. Coexistence or causative relationship?

Authors:  Lidia Rudnicka; Malgorzata Lukomska
Journal:  J Dermatol Case Rep       Date:  2012-12-31

Review 4.  Cytokines and other mediators in alopecia areata.

Authors:  Stamatis Gregoriou; Dafni Papafragkaki; George Kontochristopoulos; Eustathios Rallis; Dimitrios Kalogeromitros; Dimitris Rigopoulos
Journal:  Mediators Inflamm       Date:  2010-03-11       Impact factor: 4.711

5.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

6.  Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss.

Authors:  Gamze Serarslan; Oğuzhan Özcan; Ebru Okyay; Bahar Ünlü; Mehmet Karadağ
Journal:  Ir J Med Sci       Date:  2020-10-20       Impact factor: 1.568

7.  Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.

Authors:  P Ostojic; S Pavlov-Dolijanovic
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

8.  Serum Levels of Interleukin-2 in Patients with Alopecia Areata: Relationship with Clinical Type and Duration of the Disease.

Authors:  Emina Kasumagić-Halilovic; Semra Cavaljuga; Nermina Ovcina-Kurtovic; Lamija Zecevic
Journal:  Skin Appendage Disord       Date:  2018-02-06

9.  Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

Authors:  Enas A S Attia; Dina El Shennawy; Ashraf Sefin
Journal:  Dermatol Res Pract       Date:  2010-06-30

10.  Alopecia areata is not associated with Helicobacter pylori.

Authors:  Hisham Zayan Abdel Hafez; Ayman Mohamed Mahran; Eman M Hofny; Dalia Abdel Aziz Attallah; Doaa Sameer Sayed; Heba Rashed
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.